The a16z Show – Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Date: March 9, 2026
Host: Daisy Wolf (Andreessen Horowitz)
Guest: Dr. Andrew Huberman (Professor of Neurobiology and Ophthalmology, Stanford University)

EPISODE OVERVIEW

This episode explores the explosive growth of consumer-driven health—covering peptides, GLP-1 drugs (like Ozempic and retatrutide), the coming wave of sleep and focus tech, advances in neurobiology, and what the future of “writing” to our own biology could look like. Dr. Andrew Huberman brings both scientific rigor and candid personal insights, reflecting on the cross-section of science, media, and technology now shaping health culture.

KEY DISCUSSION POINTS & INSIGHTS

1. Shifts in Health Consciousness (02:08–07:29)

• Pandemic as a Health Wake-Up Call:
  COVID-19 fundamentally changed how people view health responsibility. The old model of relying solely on physicians is giving way to self-advocacy and experimentation.

  "We are all responsible for our own health." (Dr. Huberman, 05:19)

• Rise of Supplements and Self-Care:
  The transition from traditional health advice to mainstream adoption of supplements (vitamin D, creatine) and fitness practices (resistance training) blurred former boundaries between wellness, medicine, and biohacking.

• Mental Health & Circadian Rhythms:
  Disrupted circadian biology during lockdowns (duller days, brighter nights) worsened mental health and highlighted the vital links between light exposure, mood, and biological function.

  "Every psychiatric challenge is made worse by dim days and bright nights." (Dr. Huberman, 05:57)

2. The Culture War over Health Policy and Media (07:29–12:57)

• Media Polarization:
  Huberman describes a “paint with a broad brush” era of news, criticizing both sides for reducing nuanced topics (like food guidelines or public health measures) to partisanship.

  "Both sides are really guilty of that... But anything that gets people moving in the direction of their own health... is fantastic." (Dr. Huberman, 09:15)

• Independence in Science Communication:
  He emphasizes the need to “not belong to any camp” to realistically navigate and communicate breakthroughs, funding concerns (NIH, mRNA for cancer), and policies.

3. PEPTIDES & GLP-1 DRUGS: The End of Obesity? (12:58–18:30; 23:38–24:16)

• GLP-1s Are Mainstream:
  Stats: 1 in 7 Americans now take a GLP-1 drug (e.g., semaglutide, tirzepatide); 20% have tried them. Retatrutide (Lilly’s next-gen GLP) could make healthy weight widely attainable, possibly resulting in "eradicating obesity" for much of the population.

  "In theory, you could eradicate obesity. People can lose up to a third of their body weight." (Dr. Huberman, 00:27; 13:19)

• Risks with Black and Gray Market Peptides:
  Regulatory gray zones are fueling huge experimentation, especially with substances like BPC-157 (“body protection compound”). Huberman advises strong caution, noting lack of long-term human data and unknowns with unregulated sourcing.

  • Quote: "Who's doing research on these peptides at home?... It could start going awry and then get a tumor or something like that." (Dr. Huberman, 00:44; 18:09)

• Growth Hormone Secretagogues & Looksmaxing:
  Explains the arc from legitimate medical uses (tissue repair, height in kids) to trendier, riskier applications (tan, libido, muscle, “looksmaxing”), repeatedly warning that side effects can be serious and some outcomes irreversible.

  • Memorable moment: "People hear erection, fat loss, energy, tan, like oh great... This isn't the kind of thing you do to like go on vacation. You got to be real careful with these things." (Dr. Huberman, 24:16)

4. Sleep Tech and Focus: The Next Biohacking Frontier (26:53–29:08; 29:22–33:28)

• Future Sleep Tech:
  Huberman foresees a shift from crude “read-only” sleep tracking to “write-to” tech—gadgets directly modulating core body temperature, light exposure, or even eye movements to trigger and deepen sleep.

  "Someday... you’ll go to sleep with a little thing in your palm or on your feet, and your core body temperature will just drop... It’s just so easy to move these things to the body." (Dr. Huberman, 29:32)

• Alertness and Focus Medications:
  Discusses Modafinil, Adderall, and emerging drugs like Sunosi for focus and wakefulness, but sounds a strong note of caution:

  • Quote: "You always pay the piper somehow, either in sleep or in cardiac challenges. You don't want to stimulate the sympathetic nervous system so much for so often, it can probably shorten your life." (Dr. Huberman, 28:40)

• Peptides for Focus:
  While GLPs are used off-label for mental focus and even reducing alcohol cravings, Huberman dreams of a stimulant-free "noise reducer" that safely sharpens attention, but notes risks always lurk, whether physical or cognitive.

• Carbohydrates and Sleep:
  Ending dietary dogma, he offers practical sleep advice:

  "If you’re gonna have carbohydrates at any time, should be within a couple hours after resistance training or maybe three, four hours before sleep... People who reduce their carbohydrate intake too much are...not going to sleep well." (Dr. Huberman, 33:25)

5. From Reading to Writing Human Biology (33:28–39:49)

• Continuous Biomarker Monitoring:
  Predicts multi-biomarker wearables (glucose, cortisol, perhaps more) will become routine, continuously reading our internal states and eventually allowing targeted “write” interventions (right dose, right moment).

  • Quote: "I can’t overstate the importance of...a big morning cortisol pulse and then you want that to trough in the late afternoon and stay low. You get that and you win 90% of the game." (Dr. Huberman, 31:27)

• DIY Biochemistry Cocktail:
  Envisions a future where everyday people “custom blend” their peptides, micronutrients, and other molecules for precise, stackable outcomes in energy, sleep, and cognition.

• Neurotechnology for Focus:
  Predicts the next big leap is non-invasive tools (glasses, masks, vagal nerve stimulation) that let users achieve “on-demand” states of focus or calm, bypassing drugs.

  "Most of the access to the brain and nervous system is...through the eyes, ears, and the superficial nerves that run around there...that’s the body area and the sorts of things I’d be really focused on." (Dr. Huberman, 39:28)

6. The Evolution & Limits of Longevity (41:59–44:33)

• AI & Health Protocols:
  AI excels at summarizing health advice but misses the human element in motivating behavior change; delving into mechanisms, not just rules, is vital for real change.

  • Quote: "The probability that we take on a protocol or change our behavior is highly dependent on ...how we learn the information. When you understand mechanism...it gives a higher probability that somebody is going to implement the advice." (Dr. Huberman, 40:27)

• Lifespan Realism:
  Huberman is skeptical about “longevity escape velocity” but excited about advances like using young or “exercise blood” for rejuvenation, and banking one’s own blood for future therapies.

  "It’s pretty clear that the genetic upper limit is about 120. And for most of us, it's probably closer to about 105. So aim for 100 is my motto." (Dr. Huberman, 42:04)

7. Octopus Intelligence and AI (44:33–50:24)

• Personal Curiosity:
  Dr. Huberman shares his unconventional quest to translate octopus camouflage patterns into meaningful communication via AI, arguing we should try to understand animals on their own terms rather than training them to be like humans.
  • Quote: "I'm interested in what the octopus understands about the world and can communicate that to me, because I don’t know that stuff...Why would I want to teach an octopus to play a piano?" (Dr. Huberman, 48:49)

NOTABLE QUOTES & MEMORABLE MOMENTS

• "We are all responsible for our own health." — Dr. Andrew Huberman (05:19)
• "Every psychiatric challenge is made worse by dim days and bright nights." — Huberman (05:57)
• "In theory, you could eradicate obesity. People can lose up to a third of their body weight." — Huberman (00:27, 13:19)
• "You don't want to stimulate the sympathetic nervous system so much for so often, it can probably shorten your life." — Huberman (00:00, 28:40)
• "You heard it here. You can have carbs at dinner." — Daisy Wolf (33:25)
• "The real holy grail...is the ability to dial in cognitive states...Most of the access to the brain...is through the eyes, ears, and the superficial nerves." — Huberman (39:34)
• "Aim for 100 is my motto. Just aim for 100 healthy." — Huberman (42:12)
• "I'm interested in what the octopus understands about the world ...Why would I want to teach an octopus to play a piano?" — Huberman (48:49)

TIMESTAMPS FOR IMPORTANT SEGMENTS

• 02:08–07:29: Pandemic’s impact on health agency & self-care
• 13:19–18:30: Revolution and risks in GLP-1 drugs, BPC157, peptide culture
• 23:38–24:16: Melanitan, “looksmaxing,” and the dangers of playing with powerful peptides
• 26:53–29:08: Trends in focus and alertness drugs (Adderall, Modafinil, Sunosi)
• 29:22–33:28: Predictions for next-gen sleep and biomarker “writing” tech
• 33:28–39:49: Non-invasive neurotech, coming revolution in focus modulation
• 41:59–44:33: Longevity realism, banking exercise blood, young blood rejuvenation
• 44:33–50:24: Cuttlefish, octopuses, and AI — decoding nonhuman intelligence

CONCLUSION

Huberman paints a vivid picture of the near future: widespread safe use of peptides, personalized biology cocktails, next-level sleep and focus tech, real-time biochemistry monitoring, and a public increasingly taking the steering wheel for their own health. He grounds the optimism in healthy skepticism, scientific caution, and a call for more nuanced media and policy. The episode ends with a quirky but profound foray into translating animal cognition with AI—a metaphor for listening deeply, not just projecting our own narratives onto the future of health.